CD274 and neoplasm: As shown in Fig. 5E, MiBaMc-triggered PDT/PTT synergized with an anti-PD-L1 blocking antibody show a potent tumor inhibition in two tumor-bearing mouse models (immunogenic TNBC and colorectal cancer).